Literature DB >> 25373548

[Implementation and use of biosimilars in the therapy of inflammatory rheumatic diseases: Statement of the German Society of Rheumatology].

H-M Lorenz1, J Braun, K Krüger, M Schneider.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25373548     DOI: 10.1007/s00393-014-1505-x

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  1 in total

1.  Biosimilars in rheumatology: the wind of change.

Authors:  Christian K Schneider
Journal:  Ann Rheum Dis       Date:  2013-03       Impact factor: 19.103

  1 in total
  1 in total

1.  [Revised version of the statement by the DGRh on biosimilars-update 2017].

Authors:  J Braun; H M Lorenz; U Müller-Ladner; M Schneider; H Schulze-Koops; Ch Specker; A Strangfeld; U Wagner; T Dörner
Journal:  Z Rheumatol       Date:  2018-02       Impact factor: 1.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.